Healthcare innovation is advancing. Capital has not kept pace. The constraint is economic alignment — value creation and value capture are still disconnected in most preventative health models. Innoviance closes that gap.
Innoviance is an early-stage investment platform focused exclusively on European preventative health. Alongside investing, we advise VC funds, family offices, and healthtech companies at capital and governance inflection points, and speak on the economics that will determine how this market evolves.
Everyone agrees prevention is better. Capital still flows disproportionately into late-stage intervention — not because prevention does not work, but because it does not capture the value it creates under current system constraints.
Return Capture Gap = Value Created − Value Captured.
In prevention, this gap is structurally large.
We focus on models where it closes.
Prevention fails financially for three reasons: returns are delayed beyond most capital cycles, attribution is hard, and the entity funding prevention rarely captures the downstream savings. This is a capital allocation problem, not a science problem. The question we ask of every company: does the model convert long-term health value into near-term financial signals? Does it embed into existing workflows and shorten the feedback loop between intervention and return?
Investments while GP at Antler: Clear.bio · Respiq · Hypherdata
LSH Capital Match — Amsterdam Economic Board, 2025
Innoviance Consulting works selectively with VC funds, family offices, and healthtech companies at inflection points — where decisions are consequential and experienced, independent thinking matters. Engagements are led by Kim Oreskovic.
0100 Europe LP Conference — Moderator, 2024
Kim speaks at LP forums, investor roundtables, health innovation conferences, and government advisory sessions — and writes on the same themes. The perspective is that of an investor and board director who has sat on both sides of the table.
If that framing resonates — whether you are an investor, a board looking for an independent director, a founder, or a conference organiser — the best place to start is LinkedIn.
I am an investor and board director focused on capital allocation in healthcare — specifically the structural shift from reactive systems to preventative, data-driven models.
As a Chartered Accountant with a pre-med foundation, I operate at the intersection of science, capital, and execution. I write and speak on capital allocation, prevention economics, and healthcare system design.
English · Dutch · French — Europe, North America, Asia